A study reveals that dronabinol, a synthetic THC, decreases agitation in Alzheimer’s patients by 30%, according to recent findings. Agitation impacts about 40% of Alzheimer’s patients, often leading ...
In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback